Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Sky Ventures Group
AddedFeb 15, 2024
UpdatedJun 28, 2026
Sky Ventures Group

Sky Ventures Group

Operating

Boston-based seed funding provider for early-stage life science and healthcare companies.

Location
Boston, MA, US
Founded
2015
Firm
Compare
Portfolio
Employees
Website

Sky Ventures Group is a Boston-based investment firm specializing in seed funding for early-stage life science and healthcare companies. The firm typically invests in seed rounds, with occasional participation in Series A rounds. Their investment focus is on nurturing next-generation healthcare innovations, leveraging a network of diverse and visionary investors, including corporate venture capital, foundations, large corporations, family offices, and individual angel investors.

Notable portfolio companies include Amopportunities, Bioz, Humon, and Pathology Watch. Sky Ventures Group collaborates with strategic partners such as Johnson & Johnson, Roche, Merck, and CVS, among others. The firm is led by key decision-makers with extensive experience in the healthcare sector. Sky Ventures Group offers unique value-add services to its portfolio companies, including access to a broad network of industry leaders and tailored strategic support to foster growth and innovation.

Sky Ventures Group - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count10
Total Portfolio Exits1

Top Investment Stages

Seed10 (76.9%)
Series A3 (23.1%)

Stage Mix

Seed 77%Series A 23%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Hilltop Biosciences logo

Hilltop Biosciences

Naveris logo

Naveris

Pathology Watch logo

Pathology Watch

Medcura logo

Medcura

Amopportunities logo

Amopportunities

LogicInk logo

LogicInk

Humon logo

Humon

Agile EndoSurgery logo

Agile EndoSurgery

Bioz logo

Bioz

Biolinq logo

Biolinq

Curtana Pharmaceuticals logo

Curtana Pharmaceuticals

Sky Ventures Group - Similar Investment Firms

SkyRiver Ventures logo

SkyRiver Ventures

Skyline Ventures logo

Skyline Ventures

Skyview Capital logo

Skyview Capital

skyviewcapital.com

Boutique Venture Partners logo

Boutique Venture Partners

boutiquevc.com

Skywood Ventures logo

Skywood Ventures

skywood.com

SkyChee Ventures logo

SkyChee Ventures

Skyview Ventures logo

Skyview Ventures

Healthcare Ventures logo

Healthcare Ventures

hcven.com

Avestria logo

Avestria

avestria.vc

Seae Ventures logo

Seae Ventures

Endpoint Ventures logo

Endpoint Ventures

endpoint.vc

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Skywell Capital Partners logo

Skywell Capital Partners

Mass General Brigham Ventures logo

Mass General Brigham Ventures

SteelSky Ventures logo

SteelSky Ventures

Sky Ventures Group - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 7300Business Services
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end